Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Maggi

Showing results (261-270 of 469) with videos related to

Pageof 47
Sort By:
European Urology|January 26, 2016
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaMauro Gacci, Karl-Erik Andersson, Christopher Chapple, et al.
Cancers|November 25, 2023
Multiparametric Ultrasound for Diagnosing Testicular Lesions: Everything You Need to Know in Daily Clinical PracticeCarlotta Pozza, Marta Tenuta, Franz Sesti, et al.
Journal of Neuroendocrinology|February 21, 2020
The G protein-coupled oestrogen receptor, GPER1, mediates direct anti-inflammatory effects of oestrogens in human cholinergic neurones from the nucleus basalis of MeynertErica Sarchielli, Giulia Guarnieri, Eglantina Idrizaj, et al.
The Journal of Sexual Medicine|April 19, 2012
A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaMauro Gacci, Gianni Vittori, Nicola Tosi, et al.
The Journal of Sexual Medicine|January 26, 2013
Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunctionGiovanni Corona, Giulia Rastrelli, Valdo Ricca, et al.
The Journal of Sexual Medicine|August 18, 2012
Metabolic and cardiovascular outcomes of fatherhood: results from a cohort of study in subjects with sexual dysfunctionAlessandra D Fisher, Giulia Rastrelli, Elisa Bandini, et al.
Andrology|June 23, 2026
Testosterone Therapy After Radical Prostatectomy: Insights From a Systematic Review and Meta-AnalysisGiovanni Corona, Luís Afonso Morgado, Paolo Capogrosso, et al.
Reviews in Endocrine & Metabolic Disorders|February 22, 2021
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysisGiovanni Corona, Alessandro Pizzocaro, Walter Vena, et al.
BJU International|March 8, 2014
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysisMauro Gacci, Giovanni Corona, Linda Vignozzi, et al.
The Journal of Urology|September 18, 2007
Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot studyMauro Gacci, Giulio Del Popolo, Angelo Macchiarella, et al.
Pageof 47

Showing results (261-270 of 469) with videos related to

Sort By:
Pageof 47
European Urology|January 26, 2016
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaMauro Gacci, Karl-Erik Andersson, Christopher Chapple, et al.
Cancers|November 25, 2023
Multiparametric Ultrasound for Diagnosing Testicular Lesions: Everything You Need to Know in Daily Clinical PracticeCarlotta Pozza, Marta Tenuta, Franz Sesti, et al.
Journal of Neuroendocrinology|February 21, 2020
The G protein-coupled oestrogen receptor, GPER1, mediates direct anti-inflammatory effects of oestrogens in human cholinergic neurones from the nucleus basalis of MeynertErica Sarchielli, Giulia Guarnieri, Eglantina Idrizaj, et al.
The Journal of Sexual Medicine|April 19, 2012
A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaMauro Gacci, Gianni Vittori, Nicola Tosi, et al.
The Journal of Sexual Medicine|January 26, 2013
Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunctionGiovanni Corona, Giulia Rastrelli, Valdo Ricca, et al.
The Journal of Sexual Medicine|August 18, 2012
Metabolic and cardiovascular outcomes of fatherhood: results from a cohort of study in subjects with sexual dysfunctionAlessandra D Fisher, Giulia Rastrelli, Elisa Bandini, et al.
Andrology|June 23, 2026
Testosterone Therapy After Radical Prostatectomy: Insights From a Systematic Review and Meta-AnalysisGiovanni Corona, Luís Afonso Morgado, Paolo Capogrosso, et al.
Reviews in Endocrine & Metabolic Disorders|February 22, 2021
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysisGiovanni Corona, Alessandro Pizzocaro, Walter Vena, et al.
BJU International|March 8, 2014
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysisMauro Gacci, Giovanni Corona, Linda Vignozzi, et al.
The Journal of Urology|September 18, 2007
Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot studyMauro Gacci, Giulio Del Popolo, Angelo Macchiarella, et al.
Pageof 47